Dr. Reddy’s Laboratories Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +9,564.5% | +51.8% | +8.5% | +11.7% | -3.2% | +24.9% | +168.2% | -23.4% | +38.9% | +1.2% | +6.3% | +29.5% | +20.2% | +13.7% | +12.1% | +4.4% | -9.0% | +0.9% | +8.3% | +13.5% | -98.5% | +8,288.8% | +14.7% | +13.5% | +16.6% | +8.6% | |
| – | +6,124.5% | +20.1% | +13.9% | +19.8% | +0.2% | +32.6% | +175.5% | -28.3% | +33.9% | +3.0% | +1.5% | +26.1% | +28.2% | +1.2% | +11.4% | -0.6% | +0.0% | +5.2% | +7.1% | +14.4% | -98.4% | +7,893.6% | +6.0% | +8.5% | +16.9% | +23.6% | |
| – | +24,371.5% | +86.6% | +4.7% | +5.5% | -6.2% | +17.8% | +160.5% | -17.9% | +43.7% | -0.4% | +10.8% | +32.4% | +13.6% | +25.1% | +12.7% | +8.1% | -15.1% | -2.6% | +9.3% | +12.7% | -98.6% | +8,671.8% | +22.4% | +17.4% | +16.4% | -2.1% | |
| – | +16,544.5% | +46.1% | +85.1% | +45.6% | +40.4% | -23.0% | +14.4% | +43.1% | +14.3% | -6.0% | +33.4% | +16.8% | +29.8% | +61.6% | +40.7% | +2.2% | +9.6% | -6.6% | -14.6% | -1.3% | -98.6% | +8,290.1% | +10.9% | +18.0% | +19.7% | -7.5% | |
| – | – | +27.1% | +5,559,620.0% | -100.0% | -96.7% | +3.2% | +0.0% | +107.4% | +2,839.3% | +21.3% | +6.2% | +19.1% | +12.0% | -9.0% | +5.7% | +1.0% | +3.6% | +0.7% | -1.8% | +6,990.4% | +8.8% | +13.8% | -25.2% | +66.1% | +21.6% | -36.2% | |
| – | – | +25.4% | +46.6% | +26.3% | +20.5% | -0.2% | +88.8% | +11.9% | +14.8% | +1.7% | +7.4% | +23.1% | +14.0% | +28.3% | +18.8% | +6.0% | +3.5% | -0.7% | -2.9% | +24.7% | -98.9% | +9,637.8% | -2.6% | +16.6% | +23.7% | +16.1% | |
| – | +8,416.1% | +240.6% | -34.1% | -37.5% | -117.6% | – | +678.3% | -70.2% | -184.4% | – | +528.9% | +44.5% | +15.7% | +23.3% | +1.0% | +12.7% | -54.4% | -11.7% | +75.3% | -23.4% | -97.3% | +6,732.0% | +93.9% | +18.5% | +6.1% | -32.0% | |
| – | – | – | – | – | – | – | – | – | +54.4% | -77.7% | -2.7% | +194.8% | -4.6% | +25.1% | -14.3% | -24.4% | -23.2% | +24.3% | +12.8% | -98.4% | +6,896.8% | -1.2% | +49.1% | +19.8% | +65.3% | +39.0% | |
| – | +6,809.1% | +378.5% | -22.7% | -35.0% | -95.8% | +1,667.9% | +456.2% | -67.3% | -216.2% | – | +506.1% | +48.4% | +17.4% | +22.7% | +5.9% | -3.6% | -46.0% | -2.1% | +56.5% | -19.7% | -98.0% | +8,977.5% | +86.9% | +19.1% | +6.8% | -24.9% | |
| – | +21,378.1% | -52.0% | +158.3% | -82.5% | -235.8% | – | +355.4% | -204.2% | – | -16.0% | +42.4% | +199.6% | +16.6% | +4.0% | +17.5% | +19.1% | -63.3% | +73.5% | -19.6% | -140.2% | – | +6,963.5% | +75.3% | +5.8% | +20.7% | -33.5% | |
| – | +5,240.1% | +564.9% | -28.3% | -29.6% | -91.5% | +673.0% | +472.5% | -50.0% | -210.5% | – | +933.7% | +29.2% | +17.6% | +28.2% | +3.1% | -9.8% | -39.8% | -18.5% | +91.7% | +3.7% | -98.8% | +10,049.5% | +91.2% | +23.6% | +1.5% | -20.3% | |
| – | – | +152.5% | -27.5% | -34.8% | -64.0% | +165.4% | +427.0% | -48.8% | -79.7% | +343.1% | +155.5% | +20.9% | +10.6% | +47.4% | +3.8% | +15.9% | -37.9% | -4.6% | +50.3% | +17.6% | -98.7% | +8,329.7% | +65.1% | +18.8% | +9.3% | -13.8% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.